Seth Pincus

10PUBLICATIONS
16CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)Biologically active moleculesMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Apr 17, 2026
Anti-HIV Immunotoxin and Antibody-Drug Conjugate Display Both Common and Distinct Effects in Killing Target Cells.

|Feb 20, 2026
Comparative In Vitro Evaluation of Anti-HIV Immunotoxin, Antibody-Drug Conjugate, and Radioimmunoconjugate Targeted by the Same Antibody.

Anne-Sophie Kuhlmann, Tami Peters, Donald K Hamlin

|Dec 30, 2025
Multi-Component Analysis of Protein- and DNA-Coated Magnetic Nanoparticles Using Electrochemical Impedance Spectroscopy with Interdigitated Electrode Sensors.

Kestley Lutey, Patrick B White, Hiram Cammon

|Sep 27, 2025
J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of Pseudomonas Exotoxin A.

Seth H Pincus, Kun Luo, Tami Peters

|Sep 16, 2024
Conjugation of anti-HIV gp41 monoclonal antibody to a drug capable of targeting resting lymphocytes produces an effective cytotoxic anti-HIV immunoconjugate.

Seth H Pincus, Frances M Cole, Kelli Ober

|Sep 29, 2023
Soluble CD4 and low molecular weight CD4-mimetic compounds sensitize cells to be killed by anti-HIV cytotoxic immunoconjugates.

Seth H Pincus, Megan Stackhouse, Connie Watt

Pageof 2

Frequent Collaborators

3 joint publications

Valérie Copié

2 joint publications

Galen O'Shea-Stone

2 joint publications

Grant Klug

1 joint publications

Pamela A Kozlowski